- ● ONCO-241 top Q4 contributor
- ● 3 invoices crossed 60d AR
- ● Pipeline cov 27% · gap closable
Recruitment activity becomes revenue. Revenue becomes forecast. Forecast becomes board decisions. Decisions reveal contracting gaps. Pharma Watcher closes them. One closed loop.
Where revenue is actually generated. Patient activity is captured per visit, per referral, per investigator.
Activity is validated and converted into recognized revenue, invoices, AR aging and a 90-day / 12-month forecast.
CFO and COO read the numbers in one pane and decide where to lean in — and where the contracting gap is widest.
The gap surfaces tomorrow's revenue. Surface trials, sponsors and Phase II→III drugs before competitors do.
| Event | Study | Amount | Status |
|---|---|---|---|
| EV-4421 | ONCO-241 | $4,280 | ok |
| EV-4422 | CARDIO-118 | $1,820 | ok |
| EV-4423 | NEURO-077 | $4,400 | review |
| EV-4424 | DERM-302 | $980 | ok |
Every data source is wired through a contract so dummy data swaps to a live response with zero schema change. See the full list in Settings → Integrations.
Made with Emergent